Pure Global

Patient-Reported Outcomes for Lemborexant in Chinese Participants With Insomnia - Trial NCT06225947

Access comprehensive clinical trial information for NCT06225947 through Pure Global AI's free database. This phase not specified trial is sponsored by Guangdong Provincial People's Hospital and is currently Not yet recruiting. The study focuses on Insomnia. Target enrollment is 200 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06225947
Not yet recruiting
drug
Trial Details
ClinicalTrials.gov • NCT06225947
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Patient-Reported Outcomes for Lemborexant in Chinese Participants With Insomnia
A Prospective, Multi-center, 3-month, Observational Study to Evaluate the Effectiveness and Safety of Lemborexant in Chinese Patients With Insomnia in Real World Setting.

Study Focus

Insomnia

Lemborexant 5 MG

Observational

drug

Sponsor & Location

Guangdong Provincial People's Hospital

Guangzhou,Guangzhou,Guangzhou,Guangzhou,Guangzhou, China

Timeline & Enrollment

N/A

Feb 01, 2024

Jun 30, 2025

200 participants

Primary Outcome

Proportion of patients with insomnia remission

Summary

This study is a prospective, open-label, single arm, multicenter study lasting 12 weeks to
 evaluate effectiveness and safety of lemborexant(LEM). Patient self-evaluation reports and
 safety events will be collected at baseline and 4 visits during treatment.

ICD-10 Classifications

Nonorganic insomnia
Disorders of initiating and maintaining sleep [insomnias]
Sleep disorders
Sleep disorder, unspecified
Other sleep disorders

Data Source

ClinicalTrials.gov

NCT06225947

Non-Device Trial